DiaMedica Therapeutics (DMAC) Other Non Operating Income: 2017-2024

Historic Other Non Operating Income for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to $2.3 million.

  • DiaMedica Therapeutics' Other Non Operating Income rose 1514.29% to $99,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $119,000, marking a year-over-year increase of 275.00%. This contributed to the annual value of $2.3 million for FY2024, which is 17.52% up from last year.
  • According to the latest figures from FY2024, DiaMedica Therapeutics' Other Non Operating Income is $2.3 million, which was up 17.52% from $1.9 million recorded in FY2023.
  • In the past 5 years, DiaMedica Therapeutics' Other Non Operating Income ranged from a high of $2.3 million in FY2024 and a low of $82,000 during FY2021.
  • Its 3-year average for Other Non Operating Income is $1.5 million, with a median of $1.9 million in 2023.
  • In the last 5 years, DiaMedica Therapeutics' Other Non Operating Income crashed by 64.19% in 2021 and then soared by 446.46% in 2023.
  • Yearly analysis of 5 years shows DiaMedica Therapeutics' Other Non Operating Income stood at $229,000 in 2020, then tumbled by 64.19% to $82,000 in 2021, then spiked by 330.49% to $353,000 in 2022, then spiked by 446.46% to $1.9 million in 2023, then grew by 17.52% to $2.3 million in 2024.